Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells

Gene Therapy

Volumn 13, Issue 5, 2006, Pages 440-448

  Malecaze, F ^a   Decha, A ^a   Serre, B ^a   Penary, M ^b,c   Duboue, M ^a   Berg, D ^b   Levade, T ^d   Lubsen, N H ^e   Kremer, E J ^f   Couderc, B ^b,c  

^a CHU PURPAN   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d INSERM   (France)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Adenovirus vector; Apoptosis; Bax; Caspase 3; Lens epithelial cells; Posterior capsule opacification

Indexed keywords

DNA FRAGMENT; PROCASPASE 3; PROTEIN BAX; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOVIRUS VECTOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CATARACT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EX VIVO STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENS EPITHELIUM; NONHUMAN; PHACOEMULSIFICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33645148673     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302667     Document Type: Article

References (35)

1. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF et al. Posterior capsule opacification. Surv Ophthalmol 1992; 37: 73-116.
2. Nishi O, Nishi K. Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg 1999; 25: 521-526.
3. Kuchle M, Seitz B, Langenbucher A, Gusek-Schneider GC, Martus P, Nguyen NX. Comparison of 6-month results of implantation of the 1CU accommodative intraocular lens with conventional intraocular lenses. Ophthalmology 2004; 111: 318-324.
4. Nishi O. Posterior capsule opacification. Part 1: Experimental investigations. J Cataract Refract Surg 1999; 25: 106-117.
5. Germano IM, Fable J, Gultekin SH, Silvers A. Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: Preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 2003; 65: 279-289.
6. Hassan W, Sanford MA, Woo SL, Chen SH, Hall SJ. Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer. World J Urol 2000; 18: 130-135.
7. Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Traversari C et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors. Hum Gene Ther 1998; 9: 2243-2251.
8. Couderc BC, de Neuville S, Douin-Echinard V, Serres B, Manenti S, Darbon JM et al. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res 1999; 19: 472-482.
9. Malecaze F, Couderc B, de Neuville S, Serres B, Mallet J, Douin-Echinard V et al. Adenovirus-mediated suicide gene transduction: Feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits. Hum Gene Ther 1999; 10: 2365-2372.
10. Nicholson DW, Thornberry NA. Apoptosis. Life and death decisions. Science 2003; 299: 214-215.
11. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002; 2: 420-430.
12. Kagawa S, Pearson SA, Ji L, Xu K, McDonnell TJ, Swisher SG et al. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Therapy 2000; 7: 75-79.
13. Kagawa S, Gu J, Swisher SG, Ji L, Roth JA, Lai D et al. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res 2000; 60: 1157-1161.
14. McNeish IA, Bell SJ, Lemoine NR. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes. Gene Therapy 2004; 11: 497-503.
15. Lemoine NR, McNeish IA. Gene transfer: Bax to the future for cancer therapy. Gut 2004; 53: 478-479.
16. Nakamura T, Williams-Simons L, Westphal H. A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis. Oncogene 1997; 14: 2991-2998.
17. Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 2000; 165: 2886-2894.
18. Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA et al. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol 2002; 161: 643-654.
19. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
20. Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell TJ et al. Adenoviral Bak overexpression mediates caspase-dependent tumor killing. Cancer Res 2000; 60: 788-792.
21. Ashcroft M, Vousden KH. Regulation of p53 stability. Oncogene 1999; 18: 7637-7643.
22. Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene 2001; 20: 659-668.
23. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577-590.
24. Chen Q, Ash JD, Branton P, Fromm L, Overbeek PA. Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice. Oncogene 2002; 21: 1028-1037.
25. Brand K, Klocke R, Possling A, Paul D, Strauss M. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Therapy 1999; 6: 1054-1063.
26. Gwon AE, Jones RL, Gruber LJ, Mantras C. Lens regeneration in juvenile and adult rabbits measured by image analysis. Invest Ophthalmol Vis Sci 1992; 33: 2279-2283.
27. Gwon A, Gruber L, Mantras C, Cunanan C. Lens regeneration in New Zealand albino rabbits after endocapsular cataract extraction. Invest Ophthalmol Vis Sci 1993; 34: 2124-2129.
28. McAvoy JW, Chamberlain CG, de Iongh RU, Hales AM, Lovicu FJ. Peter Bishop Lecture: Growth factors in lens deveKopment and cataract: key roles for fibroblast growth factor and TGF-beta. Clin Experiment Ophthalmol 2000; 28: 133-139.
29. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371: 72-74.
30. Krag S, Andreassen TT. Mechanical properties of the human posterior lens capsule. Invest Ophthalmol Vis Sci 2003; 44: 691-696.
31. Krag S, Andreassen TT. Mechanical properties of the human lens capsule. Prog Retin Eye Res 2003; 22: 749-767.
32. Maloof A, Neilson G, Milverton EJ, Pandey SK. Selective and specific targeting of lens epithelial cells during cataract surgery using sealed-capsule irrigation. J Cataract Refract Surg 2003; 29: 1566-1568.
33. Kaliberov SA, Buchsbaum DJ, Gillespie GY, Curiel DT, Arafat WO, Carpenter M et al. Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells. Mol Ther 2002; 6: 190-198.
34. Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 1959; 47: 155-170.
35. Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol 1991; 109: 1681-1683.